Más vistos - BRVO with CME following cataract surgery 52 year old female
The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvista 271 veces51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvista 262 veces51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvista 258 veces51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvista 255 veces51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvista 254 veces51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvista 251 veces51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvista 248 veces51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvista 243 veces51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvista 242 veces51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvista 242 veces51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvista 240 veces51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvista 239 veces51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvista 238 veces51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvista 232 veces51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvista 231 veces51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvista 230 veces51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvista 230 veces51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvista 226 veces51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvista 226 veces51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvista 226 veces51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvista 220 veces51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvista 219 veces51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvista 219 veces51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvista 219 veces51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvista 217 veces51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvista 217 veces51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvista 216 veces51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvista 214 veces51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
|
|
Branch Retinal Vein Occlusion and worsened cystoid macular edema following cataract surgeryvista 213 veces51 year old female The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
|
|
|
|
|
| 29 archivos en 1 página(s) |
|
52 year old female
The patient noticed gradual vision loss in both eyes starting possibly after her last cataract surgery in May of 2022 (3 months ago). She had ECCE 3/2022 OD and 5/2022 OS. She does not have diabetes. She had glaucoma shunts placed about 2017. She has been on latanoprost and timolol. She is now getting ready to start Combigan and Bromfenac. She is also staring xidra for dry eye. She stopped the latanorpost on 8/15/22. She has had macular edema before for which she had intraocular injections which worked. She has had no injections lately. When she was getting treated for macular edema in the past she had an IOP of 60.
Medical Hx: Hypertension, Systemic. Glaucoma. Arthritis. Vertigo. Stroke.
Systemic Meds: Trimfya. NAPROXEN. LISINOPRIL.
VA OD: sc20/63-1
VA OS: sc20/50
IOP: TP: OD:12 OS:12
